Huh HyunDo, Kim WooChul, Loh John J K, Lee Suk, Kim Chul Yong, Lee SangHoon, Shin DongOh, Shin Dongho, Cho SamJu, Jang Jisun, Lim Sangwook, Cho Kwang Hwan, Kwon Sooil, Kim SeongHoon
Department of Radiation Oncology, College of Medicine, Inha University, Seoul, Korea.
Jpn J Clin Oncol. 2007 May;37(5):391-8. doi: 10.1093/jjco/hym032. Epub 2007 May 30.
It is difficult to reproduce a brachytherapy measurement because of changes in the rectal shape during inter-fraction. We constructed a multi-purpose brachytherapy phantom (MPBP) and reproduced the same conditions found in actual therapy. We further attempted to apply the measured optimal dose to reduce rectal complications.
A measured dose was administered at rectal reference point R1 using a diode detector in four patients who used a tandem and ovoid in brachytherapy for carcinoma of the cervix. A total number of 20 rectal dose measurements were performed five times per patient. In addition, discrepancies in the set-up of the diode detector were analyzed with each repetitive measurement. After reproducing the same conditions as found in actual therapy using a multi-function applicator (MFA) in the multi-purpose brachytherapy phantom constructed for this study, the dose was measured at reference points in the rectum using a thermoluminescence dosimeter (TLD).
According to the discrepancies measured in the set-up using a diode detector, Patient 1 showed a maximum value of 11.25 +/- 0.95 mm in the Y direction, Patients 2 and 3 exhibited 9.90 +/- 2.40 mm and 20.85 +/- 4.50 mm in the Z direction, respectively. Patient 4 showed 19.15 +/- 3.33 mm in the Z direction. In addition, values of the mean dose according to the position of the diode detector were recorded as 122.82 +/- 7.96-323.78 +/- 11.16 cGy. In the measured results for TLD in an MPBP, relative error for Patients 1 and 4 at the rectal reference point R2 were a maximum of 8.6 and 7.7%, respectively. For Patients 2 and 3 they were 1.7 and 1.2%, respectively. Furthermore, the dose measured at point R1 and R2 exhibited values approximately 1.7-8.6% higher than the dose calculated in advance, excluding point R1 in Patient 2. The discrepancies in the set-up owing to repetitive measurements and alterations in dosage according to these changes were not analyzed. It was evident that the relative error between the calculated and measured value was within 15%, which was allowable according to the recommendations by the American Association of Physicists in Medicine (AAPM).
The multi-purpose brachytherapy phantom constructed for this study successfully reproduced an optimal dose measured under the same conditions found in actual therapy in which the dose was precisely analyzed at a rectal reference point. In addition, these results were considered reliable and applicable for dose optimization before applying therapy using the measured data from the phantom in order to reduce rectal complications.
由于分次治疗期间直肠形状发生变化,近距离放射治疗测量难以重复。我们构建了一个多用途近距离放射治疗体模(MPBP),并重现了实际治疗中发现的相同条件。我们进一步尝试应用测量的最佳剂量以减少直肠并发症。
在四名使用串联和卵圆形进行宫颈癌近距离放射治疗的患者中,使用二极管探测器在直肠参考点R1处给予测量剂量。每位患者共进行20次直肠剂量测量,每次测量5次。此外,每次重复测量时分析二极管探测器设置中的差异。在为本研究构建的多用途近距离放射治疗体模中,使用多功能施源器(MFA)重现实际治疗中发现的相同条件后,使用热释光剂量计(TLD)在直肠参考点测量剂量。
根据使用二极管探测器测量的设置差异,患者1在Y方向上的最大值为11.25±0.95mm,患者2和3在Z方向上分别为9.90±2.40mm和20.85±4.50mm。患者4在Z方向上为19.15±3.33mm。此外,根据二极管探测器位置记录的平均剂量值为122.82±7.96 - 323.78±11.16cGy。在MPBP中TLD的测量结果中,患者1和4在直肠参考点R2处的相对误差分别最大为8.6%和7.7%。患者2和3分别为1.7%和1.2%。此外,在R1和R2点测量的剂量显示的值比预先计算的剂量高约1.7 - 8.6%,患者2的R1点除外。未分析由于重复测量导致的设置差异以及根据这些变化的剂量改变。很明显,计算值与测量值之间的相对误差在15%以内,这是根据美国医学物理学家协会(AAPM)的建议允许的。
为本研究构建的多用途近距离放射治疗体模成功重现了在实际治疗相同条件下测量的最佳剂量,其中在直肠参考点对剂量进行了精确分析。此外,这些结果被认为是可靠的,并且适用于在使用体模测量数据进行治疗前进行剂量优化,以减少直肠并发症。